1. Home
  2. TGE vs GOSS Comparison

TGE vs GOSS Comparison

Compare TGE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGE

The Generation Essentials Group Class A Ordinary Shares

HOLD

Current Price

$1.22

Market Cap

50.9M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.17

Market Cap

41.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGE
GOSS
Founded
2023
2015
Country
France
United States
Employees
166
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
41.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TGE
GOSS
Price
$1.22
$0.17
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
464.5K
15.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
$2.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.14
52 Week High
$9.24
$3.87

Technical Indicators

Market Signals
Indicator
TGE
GOSS
Relative Strength Index (RSI) 60.90 33.34
Support Level $0.94 $0.16
Resistance Level $1.22 $0.36
Average True Range (ATR) 0.16 0.02
MACD 0.03 0.01
Stochastic Oscillator 78.07 29.31

Price Performance

Historical Comparison
TGE
GOSS

About TGE The Generation Essentials Group Class A Ordinary Shares

The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: